Drugs / XH1
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT03407300 Comparator | Feb 2018 → Feb 2019 | non-small cell lung carcinoma | Haining Health-Coming Biotech Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | XH1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03407300 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Traditional Chinese Medicine XH1” NCT03407300 ↗ |